-
Je něco špatně v tomto záznamu ?
High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys
F. Rob, R. Tachezy, T. Pichlík, L. Rob, Z. Kružicová, E. Hamšíková, J. Šmahelová, J. Hercogová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
27723194
DOI
10.1111/dth.12435
Knihovny.cz E-zdroje
- MeSH
- DNA testy na papilomavirus metody MeSH
- dospělí MeSH
- dysplazie děložního hrdla epidemiologie prevence a kontrola virologie epidemiologie prevence a kontrola virologie MeSH
- hodnocení rizik MeSH
- infekce papilomavirem epidemiologie prevence a kontrola přenos virologie MeSH
- kondylomata akuminata epidemiologie prevence a kontrola virologie MeSH
- lidé MeSH
- mladý dospělý MeSH
- nádory děložního čípku epidemiologie prevence a kontrola virologie MeSH
- polymerázová řetězová reakce MeSH
- prevalence MeSH
- prospektivní studie MeSH
- průřezové studie MeSH
- rizikové faktory MeSH
- sexuální partneři * MeSH
- vakcinace * MeSH
- vakcíny proti papilomavirům aplikace a dávkování MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
We conducted a cross-sectional study on the occurrence of a specific type of genital human papillomavirus (HPV) among long-term monogamous male partners of women with cervical dysplasia and genital warts. The purpose of the study was to improve knowledge with regards to the management of these couples. The presence of genital HPV-DNA was detected by PCR with broad spectrum primers followed by hybridization. 82 males met the study criteria, 41 in each group. Genital HPV-DNA prevalence was 67.5% in the genital warts group and 72.2% in the cervical dysplasia group. The prevalence of high risk HPVs was higher in the cervical dysplasia group, while low risk HPVs were more prevalent in the genital warts group (p < .05). The prevalence of HPV in males was independent of the duration of the relationship (73.5% for 6-24 months and 66.7% for longer relationships). In conclusion, our results suggest that the prevalence of the genital HPV infection in both groups of male partners is comparable and very high, but the spectrum of HPV types varies significantly. The presence of the genital HPV infection in male sexual partners seems to be independent of the duration of the relationship. Applying the HPV vaccination to boys may prevent this phenomenon.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013487
- 003
- CZ-PrNML
- 005
- 20170428121010.0
- 007
- ta
- 008
- 170413s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/dth.12435 $2 doi
- 035 __
- $a (PubMed)27723194
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Rob, Filip $u Dermatovenereology Department, Na Bulovce Hospital, 2nd Medical Faculty Charles University, Prague, Czech Republic.
- 245 10
- $a High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys / $c F. Rob, R. Tachezy, T. Pichlík, L. Rob, Z. Kružicová, E. Hamšíková, J. Šmahelová, J. Hercogová,
- 520 9_
- $a We conducted a cross-sectional study on the occurrence of a specific type of genital human papillomavirus (HPV) among long-term monogamous male partners of women with cervical dysplasia and genital warts. The purpose of the study was to improve knowledge with regards to the management of these couples. The presence of genital HPV-DNA was detected by PCR with broad spectrum primers followed by hybridization. 82 males met the study criteria, 41 in each group. Genital HPV-DNA prevalence was 67.5% in the genital warts group and 72.2% in the cervical dysplasia group. The prevalence of high risk HPVs was higher in the cervical dysplasia group, while low risk HPVs were more prevalent in the genital warts group (p < .05). The prevalence of HPV in males was independent of the duration of the relationship (73.5% for 6-24 months and 66.7% for longer relationships). In conclusion, our results suggest that the prevalence of the genital HPV infection in both groups of male partners is comparable and very high, but the spectrum of HPV types varies significantly. The presence of the genital HPV infection in male sexual partners seems to be independent of the duration of the relationship. Applying the HPV vaccination to boys may prevent this phenomenon.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dysplazie děložního hrdla $x epidemiologie $x prevence a kontrola $x virologie $7 D002578
- 650 _2
- $a kondylomata akuminata $x epidemiologie $x prevence a kontrola $x virologie $7 D003218
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a DNA testy na papilomavirus $x metody $7 D061809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a infekce papilomavirem $x epidemiologie $x prevence a kontrola $x přenos $x virologie $7 D030361
- 650 _2
- $a vakcíny proti papilomavirům $x aplikace a dávkování $7 D053918
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a sexuální partneři $7 D012747
- 650 _2
- $a dysplazie děložního hrdla $x epidemiologie $x prevence a kontrola $x virologie $7 D002578
- 650 _2
- $a nádory děložního čípku $x epidemiologie $x prevence a kontrola $x virologie $7 D002583
- 650 12
- $a vakcinace $7 D014611
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tachezy, Ruth $u National Reference Laboratory for Papillomaviruses, Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Pichlík, Tomáš $u Obstetrics and Gynaecology Department, Motol Hospital, 2nd Medical Faculty Charles University, Prague, Czech Republic.
- 700 1_
- $a Rob, Lukáš $u Obstetrics and Gynaecology Department, Motol Hospital, 2nd Medical Faculty Charles University, Prague, Czech Republic.
- 700 1_
- $a Kružicová, Zuzana $u Dermatovenereology Department, Na Bulovce Hospital, 2nd Medical Faculty Charles University, Prague, Czech Republic.
- 700 1_
- $a Hamšíková, Eva $u National Reference Laboratory for Papillomaviruses, Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Šmahelová, Jana $u National Reference Laboratory for Papillomaviruses, Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Hercogová, Jana $u Dermatovenereology Department, Na Bulovce Hospital, 2nd Medical Faculty Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00005384 $t Dermatologic therapy $x 1529-8019 $g Roč. 30, č. 1 (2017)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27723194 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170428121331 $b ABA008
- 999 __
- $a ok $b bmc $g 1199952 $s 974265
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 30 $c 1 $e 20161009 $i 1529-8019 $m Dermatologic therapy $n Dermatol Ther $x MED00005384
- LZP __
- $a Pubmed-20170413